Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Cervical Cancer, April 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 86 articles: HTML format

Single Articles

1. ZHANG Y, Li C, Xiang Y
   Tumor immune microenvironment in cervical cancer: Histological subtype-specific immune landscapes and therapeutic implications.
   Biochim Biophys Acta Rev Cancer. 2026 Apr 1:189581.
   PubMed    
   Abstract available
   
   

2. SAINI K, Saini A, Yadav N, Kumar V, et al
   Emerging frontiers in cervical cancer diagnostics: Recent innovations in biosensors for HPV detection.
   Talanta. 2026;306:129750.
   PubMed    
   Abstract available
   
   

3. YI J, Xu C, Huo Z, Zhou H, et al
   MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells.
   Recent Pat Anticancer Drug Discov. 2026.
   PubMed    
   Abstract available
   
   

4. JIN W, Wang X, Fan Y, Huang C, et al
   A preference study for applying mHealth to improve the quality of cervical cancer screening management from a supply and demand perspective: a discrete choice experiment.
   Cancer Causes Control. 2026;37:70.
   PubMed    
   Abstract available
   
   

5. BAO YH, Xiao ML, Li YA, Ma FH, et al
   Multiparametric MRI-based Deep Learning and Radiomics for Evaluating Lymph Node Metastasis in Early-Stage Cervical Cancer.
   Radiol Imaging Cancer. 2026;8:e250345.
   PubMed    
   Abstract available
   
   

6. DU Q, Liu Q, Zhou Y, Kong Y, et al
   Primary prophylaxis with pegylated G-CSF is associated with improved treatment completion and progression-free survival in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study.
   Future Oncol. 2026 Apr 3:1-10. doi: 10.1080/14796694.2026.2654729.
   PubMed    
   Abstract available
   
   

7. MATSUKAWA H, Yugawa K, Hosokawa C, Furuichi K, et al
   Hyperspectral Imaging of Whole-Cell Region for Differentiating Cervical Squamous Intraepithelial Lesion Cytology.
   Cancer Med. 2026;15:e71746.
   PubMed    
   Abstract available
   
   

8. CHU C, Du Z, Wang J, Aili M, et al
   Targetable Biomimetic NIR-II Theranostic Nanoplatform for Highly Efficient Multimodal Imaging-Guided Photothermal Therapy of Cervical Cancer.
   Int J Nanomedicine. 2026;21:576589.
   PubMed    
   Abstract available
   
   

9. KITONSA J, Kafeero P, Ankunda V, Muhumuza R, et al
   Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda.
   Hum Vaccin Immunother. 2026;22:2654928.
   PubMed    
   Abstract available
   
   

10. ABUZOOR A, Jabin MSR, Jonker C
    Health Beliefs and Perspectives of Parents Regarding Human Papillomavirus Vaccination in Kuwait: Qualitative Study.
    JMIR Form Res. 2026;10:e85438.
    PubMed    
    Abstract available
    
    

11. NAZAROVA V, Kamzayeva N, Ukybassova T, Kozhakhmetov S, et al
    Systems analysis of the HPV-microbiome-biofilm triad.
    Front Cell Infect Microbiol. 2026;16:1767224.
    PubMed    
    Abstract available
    
    

12. FANG Y, Bai J, Bo S, Cui X, et al
    Targeting the AKT/mTOR axis: pectolinarigenin induces autophagy and apoptosis in human cervical cancer cells.
    Front Pharmacol. 2026;17:1544170.
    PubMed    
    Abstract available
    
    

13. MANICKAM R, Karnik M, Madhunapantula SV, Mohideen HS, et al
    Human CLIC5 as a Recurrent Hotspot of HPV 16 Integration in Cervical Cancer.
    J Med Virol. 2026;98:e70897.
    PubMed    
    Abstract available
    
    

14. NAKAJIMA K, Otsuka Y, Ikejiri T, Hakariya H, et al
    Evaluating the "Praise Movement" on Social Media: Perceptions of the Human Papillomavirus Vaccine in Japan.
    Yakugaku Zasshi. 2026;146:339-343.
    PubMed    
    Abstract available
    
    

15. JI L, Zhou X, Yao L
    Factors Influencing Universal Coverage of AI-Assisted Cervical Cancer Screening: Qualitative Study Based on the Macro Model of Health System.
    J Med Internet Res. 2026;28:e75372.
    PubMed    
    Abstract available
    
    

16. ABE K, Ito K, Watanabe M, Tsuneda M, et al
    Feasibility of online adaptive SBRT boost with 1.5-T MR-Linac for cervical cancer patients unsuitable for brachytherapy: a planning study.
    J Radiat Res. 2026 Apr 1:rrag013. doi: 10.1093.
    PubMed    
    Abstract available
    
    

17. ZHANG M, Gao L, Bai X
    Health-related hardiness and influencing factors among cervical cancer radiotherapy patients: A cross-sectional study.
    Support Care Cancer. 2026;34:394.
    PubMed    
    Abstract available
    
    

18. SINGH P, Sharma K, Tamrakar VK, Khare R, et al
    CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.
    Expert Rev Mol Diagn. 2026 Apr 1. doi: 10.1080/14737159.2026.2654503.
    PubMed    
    Abstract available
    
    

19. XIAOYAN Z, Xiaojuan L, Shijiao M, Xiaofan Z, et al
    Baseline inflammatory and metabolic indicators associated with early PD-1 inhibitor resistance in advanced cervical cancer: a retrospective cohort study.
    Front Med (Lausanne). 2026;13:1779898.
    PubMed    
    Abstract available
    
    

20. LU X, Su Y, Xu W, Tang T, et al
    Efficacy of induction chemotherapy combined with standard chemoradiotherapy vs. standard chemoradiotherapy monotherapy in locally advanced cervical cancer: A systematic review and meta-analysis.
    Oncol Lett. 2026;31:183.
    PubMed    
    Abstract available
    
    

21. EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al
    Burden and predictors of cervical cancer mortality in Sub-Saharan Africa: a systematic review and meta-analysis.
    Infect Agent Cancer. 2026 Mar 31. doi: 10.1186/s13027-026-00749.
    PubMed    
    
    
    

22. FEROZ B, Ebner C, Skvortsov S, Purtscheller R, et al
    Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer.
    Radiat Oncol. 2026 Mar 31. doi: 10.1186/s13014-026-02834.
    PubMed    
    
    
    

23. MOHAN N
    HPV Vaccination: A Transformative Step Towards Eliminating Cervical Cancer in India.
    Indian Pediatr. 2026 Mar 31. doi: 10.1007/s13312-026-00326.
    PubMed    
    
    
    

24. WANG D, He J, Wu S, Liu S, et al
    UM-6 remodels the tumor immune microenvironment by blocking PD-L1 N-glycosylation and promoting ERAD-mediated degradation in cervical cancer.
    Bioorg Chem. 2026;175:109788.
    PubMed    
    Abstract available
    
    

25. GARG S, Udayashankara AH, S N, F HNA, et al
    Pain management and analgesic strategies in patients with carcinoma uterine cervix undergoing intracavitary or interstitial brachytherapy.
    Support Care Cancer. 2026;34:391.
    PubMed    
    Abstract available
    
    

26. YUILL S, Naidu C, Smith M, Bateson D, et al
    Cervical Cancer Elimination in Australia and the Asia Pacific: Progress and Barriers.
    Med J Aust. 2026;224:e70164.
    PubMed    
    Abstract available
    
    

27. ABBAS G, Bokhari TH, Iqbal MA, Rehman S, et al
    Mechanosynthesis and computational studies of new imidazole-based selenium adducts as potential anticancer agents against human prostate and cervical cancer.
    Future Med Chem. 2026 Mar 31:1-11. doi: 10.1080/17568919.2026.2648984.
    PubMed    
    Abstract available
    
    

28. SATO K, Oshima N, Onuki M, Matsumoto K, et al
    Psychosocial Burden of Women With Cervical Intraepithelial Neoplasia in Japan: Results of A Web-Based Survey.
    J Obstet Gynaecol Res. 2026;52:e70258.
    PubMed    
    Abstract available
    
    

29. YAO Q, Wang K, Liu B, Jiang P, et al
    Integrated optimization of needle paths and dwell time for individualized template-guided interstitial brachytherapy.
    Med Phys. 2026;53:e70411.
    PubMed    
    Abstract available
    
    

30. SU R, Wang Y
    CLO26-078: Impact of Laparoscopic Surgical Proficiency on Survival Outcomes in Laparoscopic Radical Hysterectomy for Cervical Cancer.
    J Natl Compr Canc Netw. 2026;24.
    PubMed    
    
    
    

31. CALDERON AM, Goyal S, Peddinani B, Lopez M, et al
    EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.
    J Natl Compr Canc Netw. 2026;24.
    PubMed    
    
    
    

32. GANDHI AK, Rastogi M, Sharma V, Bhutia TD, et al
    Doses to pelvic bone marrow from intracavitary brachytherapy in carcinoma cervix: A dosimetric study.
    J Cancer Res Ther. 2026;22:84-89.
    PubMed    
    Abstract available
    
    

33. SINDHU KR, Pranitha SL, Arpitha S, Narayanan GS, et al
    Impact of the revised FIGO 2018 staging system on survival outcomes with respect to prognostic factors in cervical cancer patients treated in a tertiary care cancer center in South Karnataka.
    J Cancer Res Ther. 2026;22:27-35.
    PubMed    
    Abstract available
    
    

34. ZHAO Z, Sun C, Liu X, Yu P, et al
    GSTO1 Promotes Cell Proliferation and Stemness of Cervical Cancer via Activating PI3K/AKT/mTOR Pathway.
    FASEB J. 2026;40:e71702.
    PubMed    
    Abstract available
    
    

35. MEIRELLES I, Pinto M, Russomano F
    Cost-utility of screening with liquid cytology or p16/Ki67 dual-stain in women identified in cervical cancer screening with non 16/18 HR-HPV.
    Int J Technol Assess Health Care. 2026.
    PubMed    
    
    
    

36. TANG J, Oska C, Xie X, Small I, et al
    Impact of BMI on Organs at Risk Dose for Cervical Cancer Treated With Definitive Radiation Therapy Followed by Brachytherapy Boost.
    Cureus. 2026;18:e104301.
    PubMed    
    Abstract available
    
    

37. O'NEILL H, Bruegl A
    Immunotherapy induced sarcoidosis in a 47-year-old female with stage IIIC cervical cancer on pembrolizumab: A case report.
    Gynecol Oncol Rep. 2026;64:102062.
    PubMed    
    Abstract available
    
    

38. LI G, Chen N, Li X, Deng D, et al
    Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Pilot Randomized Controlled Trial.
    Int J Womens Health. 2026;18:595680.
    PubMed    
    Abstract available
    
    

39. HUANG X, Zhou C, Ou Y
    Case Report: Fully transvaginal extraperitoneal pelvic lymphadenectomy via retropubic access combined with radical vaginal hysterectomy or trachelectomy for early-stage cervical cancer.
    Front Surg. 2026;13:1775199.
    PubMed    
    Abstract available
    
    

40. LIU J, Ren WJ
    Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report.
    Front Oncol. 2026;16:1736364.
    PubMed    
    Abstract available
    
    

41. LI S, Wang N
    The correlation between the triglyceride-glucose index and the odds of cervical cancer.
    Front Oncol. 2026;16:1766167.
    PubMed    
    Abstract available
    
    

42. DUSHKIN A, Grishacheva T, Afanasiev S, Dushkina I, et al
    One more opportunity in early-stage cervical cancer: the role of photodynamic therapy in managing positive surgical margins.
    J Gynecol Oncol. 2026 Mar 18. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

43. HAN KH, Yang E, Kim N, Son JH, et al
    Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002).
    J Gynecol Oncol. 2026 Mar 12. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available
    
    

44. GOTLIB-MALKOWSKA J, Debska M
    Effectiveness of ChatGPT in simplifying information for Polish patients on cervical cancer screening using advanced prompting.
    Ann Agric Environ Med. 2026;33:46-52.
    PubMed    
    Abstract available
    
    

45. RAKHMANOVA M, Sakko Y, Suleimenova A, Sakhipova G, et al
    Patient acceptance of HPV self-sampling approach for cervical cancer screening: evidence from a pilot study in Kazakhstan.
    Ann Med. 2026;58:2645175.
    PubMed    
    Abstract available
    
    

46. CASTLE PE
    Declining cervical cancer incidence in young women living in the United States: is it time to stop screening them?
    J Natl Cancer Inst. 2026 Mar 29:djag041. doi: 10.1093.
    PubMed    
    
    
    

47. TANG W, Ma H, Li J, Kuang Y, et al
    Targeting cell membrane sphingolipids: a novel ceramide analog CeY-B1 inhibits migration and invasion in cervical cancer cells.
    J Transl Med. 2026 Mar 28. doi: 10.1186/s12967-026-08031.
    PubMed    
    
    
    

48. HALLSSON LR, Hoflacher AM, Stratil J, Muehler M, et al
    Cost-effectiveness studies evaluating HPV self-sampling for cervical cancer screening - a systematic review.
    BMC Health Serv Res. 2026 Mar 28. doi: 10.1186/s12913-026-14409.
    PubMed    
    
    
    

49. ENDALEW A, Kassahun M, Habtegiorgis SD, Tsega TD, et al
    Determinants of precancerous cervical lesion among HIV positive women on ART in Awi zone public health facilities, Northwest Ethiopia, 2024.
    Sci Rep. 2026;16:10729.
    PubMed    
    Abstract available
    
    

50. LUO J, Lin Y, Yi Q, Long Y, et al
    Efficacy of focused ultrasound for HPV clearance and cervical LSIL treatment: a meta-analysis.
    Sci Rep. 2026;16:10747.
    PubMed    
    Abstract available
    
    

51. WU X, Zhang H, Yang X, Li Z, et al
    Rechallenging Immunotherapy With Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Achieved Partial Response in a Heavily Treated Patient With Metastatic Cervical Cancer: Case Report.
    Clin Ther. 2026 Mar 27:S0149-2918(26)00069.
    PubMed    
    
    
    

52. MALISZEWSKI B, Ignaczak A, Skonieczna B, Pastuszynski A, et al
    Targeted delivery of doxorubicin via cholesteryl-modified cyclodextrin: Antitumor activity in breast, ovarian, and cervical cancer cell lines.
    Chem Biol Interact. 2026;432:112062.
    PubMed    
    Abstract available
    
    

53. SHEN J, Miao Z, Wang L, Huo Z, et al
    Deep Learning Can Predict the Overall Survival of Cervical Cancer Based on Histopathological Image, Gene Mutation and Clinical Information.
    IET Syst Biol. 2026;20:e70060.
    PubMed    
    Abstract available
    
    

54. CSIKOS C, Ngo MT, Vagner A, Nagy G, et al
    Enhanced Tumor-to-Background Contrast with [(52)Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.
    Pharmaceuticals (Basel). 2026;19:517.
    PubMed    
    Abstract available
    
    

55. LI J, Parhat P, Ma Y, Peng L, et al
    Exploring the Anti-Cervical Cancer Effect and Hepatotoxicity Risk of Gossypol Based on Untargeted Metabolomics and Network Toxicology.
    Pharmaceuticals (Basel). 2026;19:377.
    PubMed    
    Abstract available
    
    

56. GIORGIO V, Del Dotto V, Grandi M, Grillini S, et al
    Pathogenic Mechanisms in Cervical Cancer: Energy Metabolism, Hypoxia and Therapy.
    Life (Basel). 2026;16:450.
    PubMed    
    Abstract available
    
    

57. ZHAO S, Yang X, Zhang L, Yang D, et al
    Correlation Between Dosimetric Parameters and Hematologic Toxicity in Cervical Cancer Patients Undergoing Intensity-Modulated Pelvic Radiotherapy.
    Cancers (Basel). 2026;18:992.
    PubMed    
    Abstract available
    
    

58. ELSAYIM R, Alhamdi HW, Almuraikhi N, Alkhateeb MA, et al
    Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma.
    Genes (Basel). 2026;17:281.
    PubMed    
    Abstract available
    
    

59. MOLNAR O, Mihutiu S, Straciuc OM, Vesa A, et al
    Correction: Molnar et al. PET CT Imaging with FDG in the Therapeutical Management of Locally Advanced Cervical Cancer Diagnosed in a 43-Year-Old Patient: Case Report and Review of the Literature. Biomedicines 2025, 13, 83.
    Biomedicines. 2026;14:676.
    PubMed    
    Abstract available
    
    

60. TAN L, Li H, Liu T, Mao W, et al
    Perineural Invasion in Early-Stage Cervical Cancer: Marker of Aggressive Pathology and Increased Recurrence Risk.
    Biomedicines. 2026;14:591.
    PubMed    
    Abstract available
    
    

61. PRETI M, Gallio N, Costa S, Borella F, et al
    Opportunistic and Organized Cervical Cancer Screening: Impact on Lesion Severity and Surgical Outcomes in 9830 Cervical Conizations.
    Diagnostics (Basel). 2026;16:839.
    PubMed    
    Abstract available
    
    

62. YANG T, Guo L, Liu D, Hua K, et al
    Proteome-based molecular subtyping and therapeutic target prediction in cervical cancer.
    Biomark Res. 2026;14:35.
    PubMed    
    Abstract available
    
    

63. SITTIWONG W, Prasartseree T, Tuntapakul P, Thaweerat W, et al
    Correction: Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
    Radiat Oncol. 2026;21:42.
    PubMed    
    
    
    

64. BRIN M, Caraballo PB, Ramirez SO, Guzman L, et al
    Evaluation of a patient educational brochure to increase knowledge of cervical cancer screening among women living with HIV in La Romana.
    BMC Public Health. 2026 Mar 28. doi: 10.1186/s12889-026-27029.
    PubMed    
    
    
    

65. HACHIMI SE, Essayagh F, Essayagh M, Kazadi GB, et al
    Assessing the prevalence of non-use of cervical cancer screening in Khouribga, Morocco.
    Sci Rep. 2026;16:10858.
    PubMed    
    Abstract available
    
    

66. SARKAR S, Saha A, DAS B, DAS D, et al
    Phosphodiesterase 5 Inhibitor Sildenafil Inhibits HPV(+) Cervical Cancer Cells and Cervical Cancer Stem Cells by Apoptotic Induction and Telomerase Activity Modulation.
    Anticancer Res. 2026;46:2007-2024.
    PubMed    
    Abstract available
    
    

67. PARKER JM, Williams LR, Haines NA, Mayberry TG, et al
    Unveiling the Molecular Blueprint of Spinach Induced Anti-proliferation and Pro-apoptosis in Cervical Cancer.
    Anticancer Res. 2026;46:1833-1841.
    PubMed    
    Abstract available
    
    

68. WANG H, Luo C, Chen W, Wang Y, et al
    Folic acid-decorated chitosan nanoparticles co-delivering silymarin and docetaxel induce CDK-mediated cell cycle arrest and apoptosis in cervical cancer cell.
    Int J Biol Macromol. 2026 Mar 25:151668. doi: 10.1016/j.ijbiomac.2026.151668.
    PubMed    
    Abstract available
    
    

69. NARESH KUMAR A, Sageengran S, Mahalle PN, Guganathan L, et al
    Cervical cancer image analysis: Detection and segmentation using self-guided quantum GANs and musical chairs optimization.
    Comput Biol Med. 2026;208:111633.
    PubMed    
    Abstract available
    
    

70. YANG T, Zhang T, Yan W, Chen X, et al
    DWI-derived intratumoral, peritumoral, and habitat features for preoperative prediction of lymph node metastasis in early-stage cervical cancer using machine learning method.
    Abdom Radiol (NY). 2026 Mar 27. doi: 10.1007/s00261-026-05463.
    PubMed    
    Abstract available
    
    

71. BIEDERMAN EB, Champion VL, Head KJ, Imburgia TM, et al
    Correlates of Integrated Human Papillomavirus Vaccination and Cervical Cancer Screening Protection in U.S. Low-Income Women.
    Vaccines (Basel). 2026;14:251.
    PubMed    
    Abstract available
    
    

72. PANCZEL I, Herold M, Borbenyi E, Horanyi D, et al
    Survival Difference in Advanced-Stage Cervical and Ovarian Cancer Patients Treated with Concomitant Modulated Electro-Hyperthermia in Comparison to Classic Treatment Modalities: Results of a Pilot Study and Meta-Analysis.
    Med Sci (Basel). 2026;14:105.
    PubMed    
    Abstract available
    
    

73. TANAKA YO
    A Novel, Promising Technique for Metastatic Lymph Node Detection in Uterine Cervical Cancer.
    Radiol Imaging Cancer. 2026;8:e260111.
    PubMed    
    
    
    

74. BROOK E, Patterson K, Wijenayake N, Madin-Warburton M, et al
    The broad societal value of pembrolizumab for women's cancer in Canada.
    Future Oncol. 2026;22:939-952.
    PubMed    
    Abstract available
    
    

75. SATAKE M, Ito S, Sawano C, Scuffham P, et al
    Benefit-risk assessment of HPV vaccination programs in Australia, the United States, and Japan.
    Vaccine. 2026;78:128407.
    PubMed    
    Abstract available
    
    

76. TAN LT, Gregory DL, Prewett S, Duke SL, et al
    Long-term Clinical Outcomes of a Resource-conserving Accelerated Magnetic Resonance Imaging-guided Brachytherapy Schedule for Cervix Cancer.
    Clin Oncol (R Coll Radiol). 2026;52:104057.
    PubMed    
    Abstract available
    
    

77. GUPTA K, Mandal S, Singh M, Mala YM, et al
    The expression of p16 , epidermal growth factor receptor and CD44 in squamous cell carcinoma uterine cervix.
    Indian J Pathol Microbiol. 2026;69:48-53.
    PubMed    
    Abstract available
    
    

78. CHU K, Vidali S, Parberry A, Saull M, et al
    Evaluation of the Quality and Suitability of Self-Collected Vaginal and Urine Samples for Human Papillomavirus Testing: A Prospective Matched Study.
    BJOG. 2026;133:1262-1270.
    PubMed    
    Abstract available
    
    

79. JIA X, Da X, Shi J, Chen M, et al
    Real-World Performance of HPV DNA-Based Screening in Health Resource-Limited Areas of China: A Multicenter Implementation Study.
    Cancer Epidemiol Biomarkers Prev. 2026;35:528-539.
    PubMed    
    Abstract available
    
    

80. VIEIRA-BAPTISTA P, Lima-Silva J, Freitas G, Goncalves M, et al
    Impact of HPV vaccination after a diagnosis of cervical HSIL - a case-control study.
    Expert Rev Anticancer Ther. 2026;26:519-527.
    PubMed    
    Abstract available
    
    

81. KLOPP AH
    Longitudinal Profiling of Cervical Cancers Reveals Therapy-Induced Vulnerabilities Beyond the Checkpoint.
    Cancer Res. 2026;86:1540-1542.
    PubMed    
    Abstract available
    
    

82. CHALIF J, Morton M, Gonzalez A, McLaughlin E, et al
    Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer.
    Gynecol Oncol. 2026;208:77-84.
    PubMed    
    Abstract available
    
    

83. DOMINONI M, Rasore G, Pano MR, Gardella B, et al
    "Side effects" of cervical cancer screening: How diagnosis can impact on women's emotional status. A pilot survey.
    Int J Gynaecol Obstet. 2026 Apr 2. doi: 10.1002/ijgo.71005.
    PubMed    
    
    
    

84. TJALMA W
    Letter to the Editor: Sentinel node biopsy in cervical cancer during pregnancy: The need for clarification in FIGO guidance.
    Int J Gynaecol Obstet. 2026 Mar 27. doi: 10.1002/ijgo.70986.
    PubMed    
    
    
    

85. LUO R, Chen J, Chen Z, Wang S, et al
    MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells.
    Oncol Rep. 2026;55:101.
    PubMed    
    Abstract available
    
    

86. SHIRAKAWA S, Nagao S, Yoshio K, Mitsuhashi T, et al
    Incidence of pelvic fractures after definitive radiotherapy for cervical cancer: A retrospective multicenter cohort study (The IPFAR study).
    PLoS One. 2026;21:e0344384.
    PubMed    
    Abstract available